CSS
NARI

Cubist Systematic Strategies’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Cubist Systematic Strategies’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,300
Closed -$342K – 3675
2024
Q3 		$342K Sell
8,300
-900
-10% -$43.2K ﹤0.01% 2372
2024
Q2 		$443K Buy
+9,200
New +$408K ﹤0.01% 2185

Other funds holding NARI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Cubist Systematic Strategies's NARI Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2024, closing a stake of 166,689 shares — an estimated $6.87M sold.

Cubist Systematic Strategies first reported a position in NARI in Q3 2020 and held it in 16 quarters. The position peaked at $18.4M in Q2 2023. 258 funds tracked by Wall St. Rank hold NARI as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 166,689 Inari Medical, Inc. Common Stock shares in Q4 2024, an estimated $6.87M.
  • Cubist Systematic Strategies first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 16 quarters.
  • Cubist Systematic Strategies's Inari Medical, Inc. Common Stock position peaked at $18.4M in Q2 2023.
  • 258 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.